Xtant Medical Holdings Inc
F:XMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xtant Medical Holdings Inc
F:XMS
|
US |
|
S
|
Sky ICT PCL
SET:SKY
|
TH |
|
L
|
Lucky Cement Ltd
KAR:LUCK
|
PK |
|
D
|
Deutsche Boerse AG
XHAN:DB1
|
DE |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
E
|
Erste Group Bank AG
XHAN:EBO
|
AT |
Wall St Price Targets
XMS Price Targets Summary
Xtant Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for XMS is 1.935 EUR with a low forecast of 1.553 EUR and a high forecast of 2.422 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XMS's stock price target?
Price Target
1.935
EUR
According to Wall Street analysts, the average 1-year price target for XMS is 1.935 EUR with a low forecast of 1.553 EUR and a high forecast of 2.422 EUR.
What is the Revenue forecast for Xtant Medical Holdings Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 3%.
What is the Gross Profit forecast for Xtant Medical Holdings Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 6 years is 5%.
What is the Operating Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 6 years is 36%.
What is the Pre-Tax Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
-27%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -27%.
What is the Net Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
42%
The compound annual growth rate for Net Income over the next 6 years is 42%.
